PAPER DesRuisseaux LA, Williams VJ, McManus AJ, Gupta AS, Carlyle BC, Azami H, Gerber JA, Bolling AM, Cook CL, Betensky RA, Arnold SE

A pilot protocol to assess the feasibility of a virtual multiple crossover, randomized controlled trial design using methylphenidate in mild cognitive impairment.

Trials. 2020 Dec 11;21(1):1016. PubMed.

PAPER Salisbury D, Plocher T, Yu F

Efficacy of simultaneous aerobic exercise and cognitive training in subjective cognitive decline: study protocol for randomized controlled trial of the Exergames Study.

Trials. 2021 Jan 6;22(1):14. PubMed.

PAPER Fields T, Patterson M, Bremova-Ertl T, Belcher G, Billington I, Churchill GC, Davis W, Evans W, Flint S, Galione A, Granzer U, Greenfield J, Karl R, Kay R, Lewi D, Mathieson T, Meyer T, Pangonis D, Platt FM, Tsang L, Verburg C, Factor M, Strupp M

A master protocol to investigate a novel therapy acetyl-L-leucine for three ultra-rare neurodegenerative diseases: Niemann-Pick type C, the GM2 gangliosidoses, and ataxia telangiectasia.

Trials. 2021 Jan 22;22(1):84. PubMed.

PAPER Sen A, Akinola M, Tai XY, Symmonds M, Davis Jones G, Mura S, Galloway J, Hallam A, Chan JY, Koychev I, Butler C, Geddes J, Van Der Putt R, Thompson S, Manohar SG, Frangou E, Love S, McShane R, Husain M

An Investigation of Levetiracetam in Alzheimer's Disease (ILiAD): a double-blind, placebo-controlled, randomised crossover proof of concept study.

Trials. 2021 Jul 31;22(1):508. PubMed.

PAPER Nam JY, Lee TY, Kim K, Chun S, Kim MS, Shin JH, Sung JJ, Kim BJ, Kim BJ, Oh KW, Kim KS, Kim SH

Efficacy and safety of Lenzumestrocel (Neuronata-R® inj.) in patients with amyotrophic lateral sclerosis (ALSUMMIT study): study protocol for a multicentre, randomized, double-blind, parallel-group, sham procedure-controlled, phase III trial.

Trials. 2022 May 18;23(1):415. PubMed.

PAPER Wu C, Zhang K, Ye J, Huang X, Yang H, Yuan L, Wang H, Wang T, Zhong X, Guo J, Yu L, Xiao A

Evaluating the effectiveness of stepwise swallowing training on dysphagia in patients with Alzheimer's disease: study protocol for a randomized controlled trial.

Trials. 2022 Jun 13;23(1):490. PubMed.

PAPER Hoang K, Watt H, Golemme M, Perry RJ, Ritchie C, Wilson D, Pickett J, Fox C, Howard R, Malhotra PA

Noradrenergic Add-on Therapy with Extended-Release Guanfacine in Alzheimer's Disease (NorAD): study protocol for a randomised clinical trial and COVID-19 amendments.

Trials. 2022 Aug 1;23(1):623. PubMed.

PAPER Fu QH, Pei J, Zhou HG, Wang T, Zhan YJ, Tao L, Xu J, Zhou Q, Wang LY

Effect of acupuncture with donepezil based on syndrome differentiation on cognitive function in patients with mild-to-moderate Alzheimer's disease: a study protocol for a multicenter randomized controlled trial.

Trials. 2022 Aug 19;23(1):695. PubMed.

PAPER Kim KW, Wang Q, Koo SH, Shin BS

A single-center, randomized, parallel design study to evaluate the efficacy of donepezil in improving visuospatial abilities in patients with mild cognitive impairment using eye-tracker: the COG-EYE study protocol for a phase II trial.

Trials. 2022 Sep 27;23(1):813. PubMed.

PAPER Brundle C, Heaven A, Clegg A

Eligibility screening older research participants using remote cognitive assessment-experiences and reflections from a primary care randomised controlled trial.

Trials. 2022 Oct 8;23(1):862. PubMed.

PAPER Kleiman MJ, Plewes AD, Owora A, Grout RW, Dexter PR, Fowler NR, Galvin JE, Miled ZB, Boustani M

Digital detection of dementia (D3): a study protocol for a pragmatic cluster-randomized trial examining the application of patient-reported outcomes and passive clinical decision support systems.

Trials. 2022 Oct 11;23(1):868. PubMed.

PAPER Evans R, Brocklehurst P, Ryan J, Hoare Z

The impact of different researchers to capture quality of life measures in a dementia randomised controlled trial.

Trials. 2023 Jan 17;24(1):33. PubMed.

PAPER Voigt S, Koemans EA, Rasing I, van Etten ES, Terwindt GM, Baas F, Kaushik K, van Es AC, van Buchem MA, van Osch MJ, van Walderveen MA, Klijn CJ, Verbeek MM, van der Weerd L, Wermer MJ

Minocycline for sporadic and hereditary cerebral amyloid angiopathy (BATMAN): study protocol for a placebo-controlled randomized double-blind trial.

Trials. 2023 Jun 5;24(1):378. PubMed.

PAPER Toles M, Kistler C, Lin FC, Lynch M, Wessell K, Mitchell SL, Hanson LC

Palliative care for persons with late-stage Alzheimer's and related dementias and their caregivers: protocol for a randomized clinical trial.

Trials. 2023 Sep 25;24(1):606. PubMed. Correction.

PAPER Lombardo FL, Spila Alegiani S, Mayer F, Cipriani M, Lo Giudice M, Ludolph AC, McDermott CJ, Corcia P, Van Damme P, Van den Berg LH, Hardiman O, Nicolini G, Vanacore N, Dickie B, Albanese A, Puopolo M, TUDCA-ALS Study Group

A randomized double-blind clinical trial on safety and efficacy of tauroursodeoxycholic acid (TUDCA) as add-on treatment in patients affected by amyotrophic lateral sclerosis (ALS): the statistical analysis plan of TUDCA-ALS trial.

Trials. 2023 Dec 5;24(1):792. PubMed.